August 24, 2017 8:02 AM ET

Pharmaceuticals

Company Overview of Imprimis Pharmaceuticals, Inc.

Executive Profile

Anthony J. Principi J.D.

Independent Director, Imprimis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 12 different industries.

See Board Relationships
73$96,874

Background

Mr. Anthony J. Principi, also known as Tony, also known as J.D., serves as the Chief Executive Officer and President of The Principi Group, LLC. Mr. Principi is a Principal of The Principi Group, LLC. He served as an Advisor of TroopSwap, Inc. In 2007, Mr. Principi joined the Wounded Warrior Project and was appointed to the position of Vice President in 2011 and served on the board until 2014.  He served as the President of QTC Management Inc., since November 2005 and ...

Corporate Headquarters

12264 El Camino Real
San Diego, California 92130

United States

Phone: 858-704-4040
Fax: 858-345-1745

Board Members Memberships

2005-Present
Director
2012-Present
Independent Director
2014-Present
Director
2015-Present
Independent Director
2016-Present
Chairman

Education

BSE
United States Naval Academy
JD 1975
Seton Hall University School Of Law
MD 1967
Seton Hall University School Of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$46,875
Total Calculated Compensation$96,874
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gregory A. Demopulos M.D.Co-Founder, Chairman, Chief Executive Officer and President
Omeros Corporation
$1.0M
Rajat Rai Chief Executive Officer
Akorn, Inc.
$824.0K
Philip R. Hagerman R.Ph.Co-Founder, Chief Executive Officer & Chairman
Diplomat Pharmacy, Inc.
$388.5K
Johannes Stols Chief Executive Officer & Executive Director
Fagron NV
$1.4M
Antony Mattessich President, CEO & Director
Ocular Therapeutix, Inc.
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Imprimis Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.